IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Clinical trial NCT07104032 · RECRUITING
Trial details
- NCT number
- NCT07104032
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-12
- Primary completion
- 2027-12-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.